Covid 19 Research using Clinical Trials (Home Page)
mHealth AssessmentsWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
|
Name (Synonyms) |
Correlation |
drug679 | Inhaled budesonide Wiki | 1.00 |
Correlated MeSH Terms (3)
There is one clinical trial.
Clinical Trials
The established Insight(TM) mHealth Platform, a component of the Stephenson Cancer Center
(SCC) mHealth Shared Resource will be used to create the "Symptom Tracker" app. The Symptom
Tracker (Insight(TM)) app will enable real-time monitoring of cancer patient symptoms that
are consistent with early signs of SARS-CoV-2 infection in this high-risk population by
automatically (and securely) transferring this information to health care providers. The
primary aim of this study is to determine the feasibility, ease of use, and perceived utility
of this app to monitor symptoms and health risk behaviors among cancer patients currently
receiving chemotherapy.
NCT04397614 Sars-CoV2 Covid-19 Other: mHealth Assessments
Primary Outcomes
Measure: Percentage of ecological momentary assessments completed Time: up to 24 weeks
Measure: Percentage of satisfied mHealth app users Time: up to 24 weeks
Secondary Outcomes
Measure: Proportion of manifestation of severe disease Time: up to 24 weeks
Measure: Proportion of treatment-related toxicity Time: up to 24 weeks
Measure: Proportion of hospitalization Time: up to 24 weeks
Measure: Proportion of COVID-19 related mortality Time: up to 24 weeks
No related HPO nodes (Using clinical trials)